Bone marrow dosimetry in low volume mHSPC patients receiving Lu-177-PSMA therapy using SPECT/CT

被引：0
|
作者：
Dagmar Grob
Bastiaan M. Privé
Constantijn H. J. Muselaers
Niven Mehra
James Nagarajah
Mark W. Konijnenberg
Steffie M. B. Peters
机构：
[1] Radboud University Medical Center,Department of Medical Imaging
[2] Slingeland Hospital,Department of Healthcare and Information Technology
[3] Erasmus Medical Center,Department of Radiation Oncology
[4] Erasmus Medical Center,Department of Radiology and Nuclear Medicine
[5] Radboud University Medical Center,Department of Urology
[6] Radboud University Medical Center,Department of Medical Oncology
来源：
EJNMMI Physics | / 11卷
关键词：
Bone marrow dosimetry; Absorbed dose; Radionuclide therapy; 177-Lu-PSMA;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Investigation of image-based lesion and kidney dosimetry protocols for 177Lu-PSMA-I&T therapy with and without a late SPECT/CT acquisition
    Resch, Sandra
    Fouladgar, Sarah Takayama
    Zacherl, Mathias
    Sheikh, Gabriel T. T.
    Liubchenko, Grigory
    Rumiantcev, Mikhail
    Unterrainer, Lena M. M.
    Wenter, Vera
    Bartenstein, Peter
    Ziegler, Sibylle I. I.
    Ilhan, Harun
    Beyer, Leonie
    Boening, Guido
    Delker, Astrid
    EJNMMI PHYSICS, 2023, 10 (01)
  • [42] Influence of a late SPECT/CT acquisition and the selected fit model on lesion dosimetry for Lu-177-PSMA-I&T therapy in the context of clinical routine
    Resch, S.
    Fouladgar, S. L. Takayama
    Sheikh, G.
    Liubchenko, G.
    Rumiantcev, M.
    Zacherl, M.
    Wenter, V.
    Bartenstein, P.
    Ziegler, S.
    Ilhan, H.
    Beyer, L.
    Boening, G.
    Delker, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S643 - S643
  • [43] Investigation of image-based lesion and kidney dosimetry protocols for 177Lu-PSMA-I&T therapy with and without a late SPECT/CT acquisition
    Sandra Resch
    Sarah Takayama Fouladgar
    Mathias Zacherl
    Gabriel T. Sheikh
    Grigory Liubchenko
    Mikhail Rumiantcev
    Lena M. Unterrainer
    Vera Wenter
    Peter Bartenstein
    Sibylle I. Ziegler
    Harun Ilhan
    Leonie Beyer
    Guido Böning
    Astrid Delker
    EJNMMI Physics, 10
  • [44] PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis
    Robert Seifert
    Katharina Kessel
    Katrin Schlack
    Manuel Weber
    Ken Herrmann
    Maximilian Spanke
    Wolfgang P. Fendler
    Boris Hadaschik
    Jens Kleesiek
    Michael Schäfers
    Matthias Weckesser
    Martin Boegemann
    Kambiz Rahbar
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 1200 - 1210
  • [45] PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis
    Seifert, Robert
    Kessel, Katharina
    Schlack, Katrin
    Weber, Manuel
    Herrmann, Ken
    Spanke, Maximilian
    Fendler, Wolfgang P.
    Hadaschik, Boris
    Kleesiek, Jens
    Schaefers, Michael
    Weckesser, Matthias
    Boegemann, Martin
    Rahbar, Kambiz
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (04) : 1200 - 1210
  • [46] Effect of Bone Marrow Disease on Hematologic Toxicity and PSA Response to 177Lu-PSMA-617 Therapy
    Losee, Meryam
    Vaz, Nuno Borges Ribeiro
    Liu, Mofei
    Cheng, Su Chun
    Konik, Arda
    Ritzer, Jolivette
    Wolanski, Andrew
    Ng, Thomas
    Choudhury, Atish
    Taplin, Mary-Ellen
    Ravi, Praful
    Jacene, Heather
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [47] Analysis of PSMA expression and outcome in patients with advanced Prostate Cancer receiving 177 Lu-PSMA-617 Radioligand Therapy
    Seifert, Robert
    Seitzer, Konstantin
    Herrmann, Ken
    Kessel, Katharina
    Schaefers, Michael
    Kleesiek, Jens
    Weckesser, Matthias
    Boegemann, Martin
    Rahbar, Kambiz
    THERANOSTICS, 2020, 10 (17): : 7812 - 7820
  • [48] Dosimetry of three consecutive cycles of 177Lu-PSMA-617 therapy in patients with advanced prostate cancer
    Rahbar, Kambiz
    Surmann, Anne-Marie
    Razlaw, Natalia
    Braeuer, Axel
    Boegemann, Martin
    Schafers, Michael
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [49] 68Ga-PSMA-11-PET/MRI radiomics in patients receiving 177Lu-617-PSMA-therapy
    Roll, W.
    Schindler, P.
    Masthoff, M.
    Seifert, R.
    Boegemann, M.
    Weckesser, M.
    Rahbar, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S316 - S317
  • [50] Quantification of the trabecular bone volume fraction for bone marrow dosimetry in molecular radiotherapy by using a dual-energy (SPECT/)CT
    Salas-Ramirez, Maikol
    Tran-Gia, Johannes
    Gbureck, Uwe
    Kosmala, Aleksander
    Lassmann, Michael
    PHYSICS IN MEDICINE AND BIOLOGY, 2019, 64 (20):
12345